Cargando…

The Immunology of DLBCL

SIMPLE SUMMARY: Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoid neoplasm and includes morphologically and molecularly heterogeneous disease subtypes. Genetic aberrations of tumor cells are strongly related to the signature of the tumor microenvironment. In this re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahara, Taishi, Nakamura, Shigeo, Tsuzuki, Toyonori, Satou, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913124/ https://www.ncbi.nlm.nih.gov/pubmed/36765793 http://dx.doi.org/10.3390/cancers15030835

Ejemplares similares

Hodgkin Lymphoma: Biology and Differential Diagnostic Problem
por: Takahara, Taishi, et al.
Publicado: (2022)

Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas
por: Satou, Akira, et al.
Publicado: (2022)

Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype
por: Satou, Akira, et al.
Publicado: (2019)

An Update on the Pathology and Molecular Features of Hodgkin Lymphoma
por: Satou, Akira, et al.
Publicado: (2022)

Diagnostic approach for classic Hodgkin lymphoma in small samples with an emphasis on PD-L1 expression and EBV harboring in tumor cells: a brief review from morphology to biology
por: Takahara, Taishi, et al.
Publicado: (2023)

Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective
por: Nakamura, Hiromu, et al.
Publicado: (2023)

Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
por: Suzuki, Susumu, et al.
Publicado: (2020)

Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B‐cell lymphoma in a mouse model
por: Takahara, Taishi, et al.
Publicado: (2016)

Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens
por: Yamanaka, Shunpei, et al.
Publicado: (2023)

Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma
por: Kondo, Yutaro, et al.
Publicado: (2021)

In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients
por: Kondo, Yutaro, et al.
Publicado: (2022)

Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma
por: Ono, Shoya, et al.
Publicado: (2022)

Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma
por: Kan, Taichi, et al.
Publicado: (2021)

PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy
por: Suzuki, Yuka, et al.
Publicado: (2020)

PD‐L1 expression on tumor or stromal cells of nodal cytotoxic T‐cell lymphoma: A clinicopathological study of 50 cases
por: Yamashita, Daisuke, et al.
Publicado: (2020)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency
por: Satou, Akira, et al.
Publicado: (2021)

Prospective evaluation of 25-gauge Franseen needles for endoscopic ultrasound-guided fine-needle biopsy of solid pancreatic masses
por: Inoue, Tadahisa, et al.
Publicado: (2020)

PD-L1-expressing extranodal diffuse large B-cell lymphoma, NOS with and without PD-L1 3’-UTR structural variations
por: Takahara, Taishi, et al.
Publicado: (2022)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

DLBCL Coast to Coast
por: Tesio, Melania
Publicado: (2018)

GOALs in relapsed DLBCL
por: Rösler, Wiebke, et al.
Publicado: (2022)

Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review
por: Sakakibara, Ayako, et al.
Publicado: (2021)

EBV status has prognostic implication among young patients with angioimmunoblastic T‐cell lymphoma
por: Eladl, Ahmed E., et al.
Publicado: (2019)

Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis
por: Tsuyuki, Yuta, et al.
Publicado: (2021)

New indications and platforms for CAR‐T therapy in lymphomas beyond DLBCL
por: Iqbal, Madiha, et al.
Publicado: (2021)

DLBCL 1L—What to Expect beyond R-CHOP?
por: Stegemann, Maike, et al.
Publicado: (2022)

Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
por: Hawkes, Eliza A., et al.
Publicado: (2021)

DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
por: Vrabac, Damir, et al.
Publicado: (2021)

Cardiac Involvement by HIV-Associated DLBCL
por: Mupamombe, Charles T., et al.
Publicado: (2018)

The Tumor Microenvironment of DLBCL in the Computational Era
por: Opinto, Giuseppina, et al.
Publicado: (2020)

Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis
por: Alsaadi, Mohammed, et al.
Publicado: (2021)

The Roles of IRF-8 in Regulating IL-9-Mediated Immunologic Mechanisms in the Development of DLBCL: A State-of-the-Art Literature Review
por: Cai, Mingyue, et al.
Publicado: (2022)

Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
por: Koido, Shigeo, et al.
Publicado: (2011)

Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL
por: Zhang, Jing, et al.
Publicado: (2023)

The biology of the tumor microenvironment in DLBCL: Targeting the “don’t eat me” signal
por: Ennishi, Daisuke
Publicado: (2021)

Enhanced PD-L1 expression on tumor cells in primary CD30-positive cutaneous large T-cell lymphoma: a report of lymph node lesions of four cases
por: Takahashi, Emiko, et al.
Publicado: (2023)

Attacking MALT1 for ABC-DLBCL therapy
por: Krappmann, Daniel
Publicado: (2012)

DUSP4 phosphatase puts the brakes on DLBCL
por: Rickert, Robert
Publicado: (2015)

CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uodn7gpvnu4mmo16jdemq7pijd